Dash Bio

Boston, Massachusetts, United States · Biotechnology · 9 employees

Dash Bio is revolutionizing clinical bioanalysis to expedite drug development. By leveraging AI and robotics, we deliver higher-quality assays with turnaround times up to 10x faster than the industry average for clinical trials and GLP studies.

Funding history

Venture - Series Unknown — $30.0M — Jul 2026
Venture - Series Unknown — $11.0M — Jun 2025
Seed — $6.5M — Oct 2024

Recent signals

Jul 14, 2026: Raised $30.0M in Venture - Series Unknown
Jun 26, 2025: Raised $11.0M in Venture - Series Unknown
Oct 28, 2024: Raised $6.5M in Seed

See plans & pricing → Track Dash Bio’s funding, hiring, and signals — with verified contacts — on Fundz.